Clinical Trial: Bisphosphonate-Associated Jaw Osteonecrosis and PET Imaging
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Bisphosphonate-Associated Jaw Osteonecrosis and PET Imaging
Brief Summary:
- Bisphosphonate-associated osteonecrosis of the jaw(ONJ)is detectable by positron emission tomography(PET).
- Bisphosphonate-associated ONJ can be diagnosed and characteristically differentiated from other bony pathologies of the jaw(osteomyelitis, osteolytic lesions, and osteoradionecrosis)by PET imaging.
Detailed Summary:
Is to review medical records of approximately 1000 patients with bisphosphonate-associated ONJ who have had PET imaging at the time of diagnosis. Also to review medical records of patients who have been diagnosed with jaw osteomyelitis, osteoradionecrosis, and cancerous lytic lesions who received PET imaging at the time of diagnosis.
If sufficient information regarding presentation and treatment cannot be obtained form the medical record, approximately 300 patients will contacted by mail (and phone if necessary) by the PI or sub-investigators to question them regarding the onset of symptoms, treatment interventions, and outcomes.
Sponsor: University of Arkansas
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University of Arkansas
Dates:
Date Received: December 27, 2007
Date Started: October 2006
Date Completion:
Last Updated: October 24, 2013
Last Verified: October 2013
